You are here: Industry Insights > Takeda

News List

Takeda’s dengue shot, rival to Sanofi's Dengvaxia, hits the mark in massive phase 3 study fiercepharma
January 30, 2019
It’s no secret Sanofi has had trouble with its world-first dengue vaccine, Dengvaxia, but that hasn't dissuaded Takeda. Its own dengue shot met its goal in a pivotal phase 3 study that covered eight countries and more than 20,000 participants.
Takeda mulling sale of emerging market drugs – report pharmaphorum
January 23, 2019
Takeda could be considering selling some emerging-market drugs in a bid to cut debts following its merger with Shire that completed earlier this month, according to a press report.
Takeda looking to divest emerging-market assets in wake of Shire acquisition firstwordpharma
January 22, 2019
According to people familiar with the matter, Takeda is mulling a sale of some emerging-market drugs as the company looks to find ways to cut debt after its $62-billion takeover of Shire earlier this month, Bloomberg reported Monday.
Emerging markets drugs worth $3B could be next on Takeda’s chopping board: report fiercepharma
January 22, 2019
Looking to trade in some assets outside Japan to fund its $58 billion takeover of Shire, Takeda is reportedly eyeing a sale of some emerging-market drugs it gained in another acquisition eight years ago.
Lonza Collaborates with Takeda to Bring Cancer Treatment to Patients americanpharmaceuticalreview
January 14, 2019
Lonza announced another milestone in its multiproduct partnership with Takeda. Takeda Pharmaceutical announced in November 2018 that ....
Takeda’s Shire takeover could herald new era of pharma M&A pharmaphorum
January 10, 2019
Takeda has officially taken over Shire in a deal that could re-establish the trend for mega mergers in big pharma.
Takeda to keep consumer business, looks outside Japan for selloffs instead fiercepharma
January 09, 2019
We just turned the page on 2018, with many Big Pharma companies having planned to exit the consumer health business, but Takeda doesn’t intend to join the party even though it’s in pressing need of money after a $58 billion acquisition.
Takeda to keep consumer business, looks outside Japan for selloffs instead fiercepharma
January 09, 2019
We just turned the page on 2018, with many Big Pharma companies having planned to exit the consumer health business, but Takeda doesn’t intend to join the party even though it’s in pressing need of money after a $58 billion acquisition.
Takeda unlikely to sell OTC unit to pay Shire merger debts pharmaphorum
January 08, 2019
Takeda’s $59 billion takeover of Shire is due to close tomorrow (Tuesday) and the company’s CEO Christophe Weber has already given some strong clues about the company’s strategy once the deal completes.
Takeda strikes three new immuno-oncology deals pharmaphorum
January 07, 2019
Takeda is upping its commitment to cancer after its Shire takeover with the announcement of three new research collaborations in immuno-oncology.....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page